KFA
HAE icon

Kelleher Financial Advisors’s Haemonetics HAE Stock Holding History

Kelleher Financial Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.5K Hold
500
– – 0.01% 474
2026
Q1 		$37.3K Hold
500
– – 0.01% 417
2025
Q4 		$40.1K Hold
500
– – 0.01% 429
2025
Q3 		$24.4K Buy
+500
New +$30.9K 0.01% 416

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kelleher Financial Advisors's HAE Position: Q2 2026 in Review

Kelleher Financial Advisors held its Haemonetics (HAE) position steady in Q2 2026 at 500 shares worth $37.5K. The position accounts for 0.01% of the portfolio, ranked #474.

Kelleher Financial Advisors first reported a position in HAE in Q3 2025 and has held it in 4 quarters since. The position peaked at $40.1K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Kelleher Financial Advisors held 500 shares of Haemonetics worth $37.5K as of Q2 2026.
  • Kelleher Financial Advisors left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up 0.01% of Kelleher Financial Advisors's portfolio in Q2 2026, its #474 holding.
  • Kelleher Financial Advisors first reported a position in Haemonetics in Q3 2025 and has held it in 4 quarters since.
  • Kelleher Financial Advisors's Haemonetics position peaked at $40.1K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Kelleher Financial Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.